Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy

Overview of attention for article published in Intensive Care Medicine, August 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs: 1 blog
twitter: 62 X users

facebook: 4 Facebook pages
bluesky: 4 Bluesky users

Readers on

mendeley: 56 Mendeley

So far, Altmetric has seen 62 X posts from 62 X users, with an upper bound of 170,126 followers.

https://t.co/YyZ2uRQKQq

In critically ill patients receiving MER or Pip/taz and RRT, please check it for the optimal dosing: ✅RRT intensity ✅Anuria or urine output ✅If you need standard target/Enterobacteriacae ✅If you need higher target/P. Aeruginosa https://t.co/znkCjmNdV…

RT @ABsteward: 🆕🔥Prospective,multinational PK study by 🌟 @jasonroberts_pk Meropenem & pip/tazo optimised dosing regimens for critically ill…

うちでもこういうことやりたいんだけどなあ😇😇 https://t.co/jVPA6rxVsz

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 58 additional X posts.